Paediatric medicines: Post-authorisationThis section provides information on the European Medicines Agency's activities relating to paediatric medicines during the post-authorisation stage.HumanPaediatrics
Page contentsIn this sectionRelated contentRelated documentsRelated EU legislationContact pointTopicsFor more information on post-authorisation activities, see Post-authorisation. In this section Annual reports on deferralsDeadlines for placing paediatric medicines on the marketPaediatric requirements for variations and extensions to marketing authorisationsSubmitting results of paediatric studies (Article 46) Related content Paediatric medicines: OverviewOpinions and decisions on paediatric investigation plansPaediatric Committee Related documents Better medicines for children English (EN) (247.68 KB - PDF)First published: 24/02/2009Last updated: 18/05/2015View Related EU legislation Regulation (EC) No 1901/2006Regulation (EC) No 1902/2006 Contact point Send a questionTopicsPaediatricsShare this pageHow useful do you find this page?12345Average: